Data as of Mar 07
| +0.14 / +0.90%|
The 1 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a -16.77% decrease from the last price of 15.62.
The current consensus among 1 polled investment analysts is to Hold stock in Albany Molecular Research Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.